⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 12, 2024International Journal of Clinical Pharmacology and Therapeutics

Calcineurin inhibitors experience in unplanned pregnancies with active lupus disease: A retrospective observational study

Ä°brahim Vasi Derya YÄ±ldÄ±rÄ±m RÄ±za Can KardaÅBurcugül Kaya Rahime Duran Gizem TuÄçe Hazan Karadeniz AslÄ±han AvanoÄlu Güler Hamit Küçük Berna Göker Abdurrahman Tufan Mehmet Akif Öztürk Abdülsamet Erden

View Full Paper

Ask AI

Bookmark

Share

Abstract

To evaluate the use of calcineurin inhibitors (CNIs), specifically tacrolimus, in unplanned pregnancies with active lupus disease among patients with systemic lupus erythematosus (SLE).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Vasi et al. (2024) studied this question.

synapsesocial.com/papers/68e6f609b6db643587670b67 https://doi.org/10.5414/cp204528

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Pregnancy and neonatal outcomes in women receiving calcineurin inhibitors: A systematic review and meta‐analysismeta-analysis · 2022 · 27 citations
2Calcineurin inhibitors and the risk of preeclampsia in solid organ transplantation – Should we rethink our approach during pregnancy?review · 2026
3Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry—a historical cohort study2024 · 3 citations
4Comparison of pregnancy outcomes in Dutch kidney recipients with and without calcineurin inhibitor exposure: a retrospective studycohort · 2021 · 12 citations
5P142 A retrospective analysis of the safety of tacrolimus use and its optimal cut-off concentration during pregnancy in women with systemic lupus erythematosus: study from two Japanese tertiary referral centers2024